BACKGROUND: Diabetic nephropathy poses an increasing health problem in the Western world, and research to new leads for diagnosis and therapy therefore is warranted. In this respect, heparan sulfates (HSs) offer new possibilities because crude mixtures of these polysaccharides are capable of ameliorating proteinuria. The aim of this study is to immuno(histo)chemically profile HSs from microalbuminuric kidneys from patients with type 1 diabetes and identify specific structural HS alterations associated with early diabetic nephropathy. METHODS: Renal cryosections of control subjects and patients with type 1 diabetes were analyzed immunohistochemically by using a set of 10 unique phage display-derived anti-HS antibodies. HS structures defined by relevant antibodies were characterized chemically by means of enzyme-linked immunosorbent assay and probed for growth factor binding and presence in HS/heparin-containing drugs. RESULTS: In all patients, HS structure defined by the antibody LKIV69 consistently increased in basement membranes of proximal tubules. This structure contained N- and 2-O-sulfates and was involved in fibroblast growth factor 2 binding. It was present in HS/heparin-containing drugs shown to decrease albuminuria in patients with diabetes. The HS structure defined by the antibody HS4C3 increased in the renal mesangium of some patients, especially those who developed macroalbuminuria within 8 to 10 years. This structure contained N- and 6-O-sulfates. For 8 other antibodies, no major differences were observed. CONCLUSION: Specific structural alterations in HSs are associated with early diabetic nephropathy and may offer new leads for early diagnosis and the rational design of therapeutic glycomimetics.
BACKGROUND:Diabetic nephropathy poses an increasing health problem in the Western world, and research to new leads for diagnosis and therapy therefore is warranted. In this respect, heparan sulfates (HSs) offer new possibilities because crude mixtures of these polysaccharides are capable of ameliorating proteinuria. The aim of this study is to immuno(histo)chemically profile HSs from microalbuminuric kidneys from patients with type 1 diabetes and identify specific structural HS alterations associated with early diabetic nephropathy. METHODS: Renal cryosections of control subjects and patients with type 1 diabetes were analyzed immunohistochemically by using a set of 10 unique phage display-derived anti-HS antibodies. HS structures defined by relevant antibodies were characterized chemically by means of enzyme-linked immunosorbent assay and probed for growth factor binding and presence in HS/heparin-containing drugs. RESULTS: In all patients, HS structure defined by the antibody LKIV69 consistently increased in basement membranes of proximal tubules. This structure contained N- and 2-O-sulfates and was involved in fibroblast growth factor 2 binding. It was present in HS/heparin-containing drugs shown to decrease albuminuria in patients with diabetes. The HS structure defined by the antibody HS4C3 increased in the renal mesangium of some patients, especially those who developed macroalbuminuria within 8 to 10 years. This structure contained N- and 6-O-sulfates. For 8 other antibodies, no major differences were observed. CONCLUSION: Specific structural alterations in HSs are associated with early diabetic nephropathy and may offer new leads for early diagnosis and the rational design of therapeutic glycomimetics.
Authors: Bart Smeets; Christoph Kuppe; Eva-Maria Sicking; Astrid Fuss; Peggy Jirak; Toin H van Kuppevelt; Karlhans Endlich; Jack F M Wetzels; Hermann-Josef Gröne; Jürgen Floege; Marcus J Moeller Journal: J Am Soc Nephrol Date: 2011-06-30 Impact factor: 10.121
Authors: Sebastian S Roeder; Taylor J Barnes; Jonathan S Lee; India Kato; Diana G Eng; Natalya V Kaverina; Maria W Sunseri; Christoph Daniel; Kerstin Amann; Jeffrey W Pippin; Stuart J Shankland Journal: Kidney Int Date: 2016-12-18 Impact factor: 10.612
Authors: Trine Marita Reine; Ingrid Benedicte Moss Kolseth; Astri Jeanette Meen; Jørn Petter Lindahl; Trond Geir Jenssen; Finn Per Reinholt; Joseph Zaia; Chun Shao; Anders Hartmann; Svein Olav Kolset Journal: Diabetes Res Clin Pract Date: 2014-10-28 Impact factor: 5.602
Authors: Shoujun Chen; Deborah J Wassenhove-McCarthy; Yu Yamaguchi; Lawrence B Holzman; Toin H van Kuppevelt; Guido J Jenniskens; Tessa J Wijnhoven; Ann C Woods; Kevin J McCarthy Journal: Kidney Int Date: 2008-05-14 Impact factor: 10.612